Clarivate Analytics pegged 11 drugs set to enter the market during 2020 as potential blockbusters by 2024
Merck’s checkpoint inhibitor Keytruda (pembrolizumab) proved to be effective in yet another cancer indication, in combination with chemotherapy in patients with metastatic triple-negative breast cancer whose tumors expressed PD-L1.
Cancer deaths in the United States fell 2.2% from 2016 to 2017 – the largest single-year drop ever recorded – fueled in large part by progress against lung cancer, the leading cause of cancer death, the American Cancer Society (ACS) reported.
A Google artificial intelligence system proved as good as expert radiologists at detecting which women had breast cancer based on screening mammograms and showed promise at reducing errors, researchers in the United States and Britain reported.
The U.S. Food and Drug Administration accepted for filing Immunomedics Inc.’s Biologics License Application (BLA) seeking accelerated approval of sacituzumab govitecan for the treatment of patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease, as a complete class 2 response.
The U.S. FDA approved AstraZeneca and Daiichi Sankyo’s Enhertu for adults with unresectable or metastatic HER2-positive breast cancer who have had two or more previous anti-HER2-based treatments in the metastatic setting.
An experimental drug developed by AstraZeneca and Daiichi Sankyo kept metastatic breast cancer at bay for months in women who had exhausted other treatment options, in the first clinical study for trastuzumab deruxtecan.
A research team may have discovered a means to prevent breast cancer from spreading to other parts of the body through the blocking of a single enzyme.
Daiichi Sankyo is taking Seattle Genetics to court over the technology the two companies used to develop antibody-drug conjugates (ADCs) during a partnership that spanned seven years.
For Breast Cancer Awareness Month, BioSpace gathered examples of recent breakthroughs in breast cancer treatment.
